HOST AND TUMOR FACTORS IN CANCER METASTASIS

被引:34
作者
FIDLER, IJ
机构
[1] Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
关键词
Cancer metastasis; heterogeneity; organ specificity; selection;
D O I
10.1111/j.1365-2362.1990.tb01889.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. The process of cancer metastasis is sequential and selective and contains stochastic elements. The growth of metastases represents the endpoint of many lethal events that only few tumour cells survive. Primary tumours contain cells with heterogeneous metastatic properties, and the outcome of metastasis depends on the interplay of tumour cells with various host factors. Collectively, then, our studies and most data reported by others have led us to conclude that metastasis is a highly selective process regulated by a number of mechanisms. This belief is contrary to the once widely accepted notion that neoplastic dissemination is the ultimate expression of cellular anarchy. In fact, suggesting that cancer metastasis is a selective process is a more optimistic view in terms of cancer therapy than the one that contends that tumour dissemination is an entirely random event. A selective biological process is regulated by the interaction of tumour cells with their host, and these complex interactions can be studied and manipulated. A better understanding of the complexity of the processes of tumour evolution, progression, and metastasis should lead to improvements in the treatment of cancer. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:481 / 486
页数:6
相关论文
共 94 条
[21]   FATE OF RECIRCULATING B-16 MELANOMA METASTATIC VARIANT CELLS IN PARABIOTIC SYNGENEIC RECIPIENTS [J].
FIDLER, IJ ;
NICOLSON, GL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (06) :1867-1872
[22]  
FIDLER IJ, 1980, CANCER IMMUNOL IMMUN, V7, P201
[23]  
FIDLER IJ, 1976, CANCER RES, V36, P3160
[24]  
FIDLER IJ, 1986, CANCER RES, V46, P5167
[25]  
FIDLER ISJ, 1977, CANCER RES, V37, P3945
[26]  
FROST P, 1981, INT J CANCER, V27, P381, DOI 10.1002/ijc.2910270318
[27]  
GIAVAZZI R, 1986, CANCER RES, V46, P1928
[28]  
GIAVAZZI R, 1986, J NATL CANCER I, V77, P1303
[29]  
GIAVAZZI R, 1987, IMMUNE DEFICIENT ANI, P273
[30]  
Hanna N, 1982, Cancer Metastasis Rev, V1, P45, DOI 10.1007/BF00049480